Literature DB >> 10801262

Differential jejunal and colonic adaptation due to resection and IGF-I in parenterally fed rats.

M B Gillingham1, E M Dahly, H V Carey, M D Clark, K R Kritsch, D M Ney.   

Abstract

Patients with severe short-bowel syndrome (SBS) often require long-term total parenteral nutrition (TPN) to maintain their nutritional status because of limited intestinal adaptation. Growth factors, including insulin-like growth factor I (IGF-I), are under investigation to promote intestinal adaptation and tolerance to oral feeding. We investigated structural and functional adaptation of the jejunum and colon in four groups of rats maintained with TPN for 7 days after a 60% jejunoileal resection and cecectomy or sham surgery and treatment with IGF-I or vehicle. Resection alone did not stimulate jejunal growth. IGF-I significantly increased jejunal mucosal mass, enterocyte proliferation, and migration rates. IGF-I decreased jejunal sucrase specific activity and reduced active ion transport and ionic permeability; resection alone had no effect. In contrast, resection significantly increased colonic mass and crypt depth but had no effect on active ion transport or ionic permeability. IGF-I had minimal effects on colonic structure. IGF-I but not resection stimulates jejunal adaptation, whereas resection but not IGF-I stimulates colonic growth in rats subjected to a model for human SBS. IGF-I treatment may improve intestinal adaptation in humans with SBS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801262     DOI: 10.1152/ajpgi.2000.278.5.G700

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  14 in total

1.  Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and -5 double knockout mice.

Authors:  Sangita G Murali; Adam S Brinkman; Patrick Solverson; Wing Pun; John E Pintar; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-26       Impact factor: 4.052

2.  Colonic adaptation: a therapeutic target for short-bowel syndrome?

Authors:  Dileep N Lobo
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

3.  Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.

Authors:  Adam S Brinkman; Sangita G Murali; Stacy Hitt; Patrick M Solverson; Jens J Holst; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-28       Impact factor: 4.052

Review 4.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

5.  Intestinal intraepithelial lymphocyte derived angiotensin converting enzyme modulates epithelial cell apoptosis.

Authors:  B E Wildhaber; H Yang; E Q Haxhija; A U Spencer; D H Teitelbaum
Journal:  Apoptosis       Date:  2005-12       Impact factor: 4.677

6.  Sustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure.

Authors:  Matthew C Koopmann; Xueyan Chen; Jens J Holst; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-23       Impact factor: 4.052

7.  Is maintenance of the ileocecal valve important to the intestinal adaptation mechanisms in a weaning rat model of short bowel?

Authors:  Guilherme Garcia Barros; Ana Cristina Aoun Tannuri; Ítalo Gerardo Rotondo; Vitor Van Vaisberg; Leandro Silveira Sarmento; Cícero Mendes Neto; Suellen Serafini; Josiane de Oliveira Gonçalves; Maria Cecília Mendonça Coelho; Uenis Tannuri
Journal:  Pediatr Surg Int       Date:  2018-08-18       Impact factor: 1.827

8.  Intestinal Na+-K+-ATPase activity and molecular events downstream of interferon-gamma receptor stimulation.

Authors:  Fernando Magro; Sónia Fraga; Tomé Ribeiro; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2004-07-26       Impact factor: 8.739

9.  Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.

Authors:  Matthew C Koopmann; David W Nelson; Sangita G Murali; Xiaowen Liu; Mark S Brownfield; Jens J Holst; Denise M Ney
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 May-Jun       Impact factor: 4.016

10.  Colonic GLP-2 is not sufficient to promote jejunal adaptation in a PN-dependent rat model of human short bowel syndrome.

Authors:  Matthew C Koopmann; Xiaowen Liu; Christopher J Boehler; Sangita G Murali; Jens J Holst; Denise M Ney
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-07-30       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.